ECP treatment for stable angina while waiting for heart care
Part of Heart & circulation, Pain clinical trials.
This trial studies whether ECP (a non-surgical treatment that improves blood flow to the heart) can reduce symptoms in people with stable angina who may need or are waiting for heart bypass surgery, or are being managed with medicines instead. It may help you feel better and need less urgent care—if you meet the study’s medical and personal requirements.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be age 18 or older
- Have diagnosed stable angina (chest pain that is predictable with activity, not sudden)
- Have specific heart artery blockage patterns (2-vessel or 3-vessel disease) and be a CABG (bypass) candidate or choosing medical treatment because surgery risk is high
- Not be planning an urgent bypass surgery, and have started your best heart medicines within the last 2 weeks
- Live in Bandung City (or nearby) and be able and willing to follow study visits and sign consent
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests if a non-invasive treatment called EECP (which uses leg cuffs to improve blood flow) can reduce harmful inflammation and help organs recover after heart surgery. It may benefit patients with heart conditions like angina, heart attack, or heart failure who are about to undergo surgery.
This study tests whether a non‑invasive treatment called enhanced external counterpulsation (EECP) can help reduce stiffness in the arteries of people on chronic hemodialysis. It may improve heart health and make dialysis more effective.
This study looks at treatment options for adults with significantly reduced heart pumping strength and extensive coronary artery disease. It may help people who are at higher risk due to widespread blocked heart arteries, but eligibility depends on recent heart events and bleeding risk.
This study looks at whether EECP (a non-surgical therapy that helps blood flow) improves outcomes in people who recently had their first ischemic stroke and have a narrowed or blocked artery. It also aims to predict who may benefit most based on health data.
This trial studies people who have chest pain (angina) due to problems with the heart’s small arteries, not a big blockage. It aims to test whether treatment approaches can help these patients by better understanding the cause of their heart-related symptoms.
This trial compares two ways to restore blood flow to the heart—bypass surgery (CABG) or stents (PCI)—in people whose heart pumps weakly (LVEF 40% or less). It aims to find which method works better for chest pain or recent heart issues.
Hear when a new Angina Pectoris trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.